Arcturus Therapeutics Holdings (ARCT) FCF Margin (QoQ) (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) FCF Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Arcturus Therapeutics Holdings 164.57 Mn -46.81 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -71,900.00
Dec 31, 2025 -12,322.00
Sep 30, 2025 -8,072.00
Jun 30, 2025 9,972.00
Mar 31, 2025 -11,881.00
Dec 31, 2024 5,597.00
Sep 30, 2024 390.00
Jun 30, 2024 -4,586.00
Mar 31, 2024 -1,038.00
Dec 31, 2023 7,013.00
Sep 30, 2023 -55,353.00
Jun 30, 2023 52,335.00
Mar 31, 2023 -14,688.00
Dec 31, 2022 43,561.00
Sep 30, 2022 -19,904.00
Jun 30, 2022 84,089.00
Mar 31, 2022 -24,206.00
Dec 31, 2021 -6,896.00
Sep 30, 2021 100,213.00
Jun 30, 2021 35,831.00